Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07206537) titled 'The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome' on Sept. 26.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).
Primary Sponsor: Ain Shams University
Condition:
Pediatrics Nephrology
Intervention:
Drug: Vitamin K 2
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: April 1, 2025
Target Sample Size: 60
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study/NCT07206537...